NON-SERIOUS ADVERSE EVENTS (AE)
Examples of an AE includes • Significant or unexpected worsening or exacerbation of the condition/ indication under study. • Exacerbation of a chronic or intermittent pre-existing condition including either an increase in frequency and/or intensity of the condition. • New condition(s) detected or diagnosed after investigational product administration even though it may have been present prior to the start of the study. • Signs, symptoms, or the clinical sequelae of a suspected interaction. • Signs, symptoms, or the clinical sequelae of a suspected overdose of either investigational product or a concomitant medication (overdose per se should not be reported as an AE/SAE). • Significant failure of expected pharmacological or biological action.
text
If "yes" to non-serious adverse events, record each event separately by fulfilling the following items.
Diagnosis Only (if known) Otherwise Sign/Symptom
text
start date of non-serious adverse event
date
outcome of non-serious adverse event
integer
end date of non-serious adverse event
date
maximum intensity of non-serious adverse event
text
change in investigational product dose due to non-serious AE
text
Did the subject withdraw from study as a result of this AE?
text
Is there a reasonable possibility that the AE may have been caused by the investigational product?
text